select study semaglutide AHA Late Breaking Science: Day 1 Highlights 🫀SELECT Trial: and Cardiovascular Outcomes in Obesity without Diabetes ✓: ⬇️ 20% Risk of a composite of cardiovascular death ❤️, nonfatal myocardial infarction, or Long-term weight loss effects of

Symptoms often improve over time but should be monitored closely

For adults 19+

Given the high prevalence of unreported CAM use in oncology patients, clinicians must proactively inquire about non-prescription products and consider potential interactions during treatment planning

Weeks 24 through 40 continue at a slower but steady pace (approaching 24% cumulative)

Lauren Hartman: Amongst my colleagues, amongst other adolescent medicine doctors and other adolescent medicine doctors specifically with eating disorder expertise, there's a lot of concern and a lot of kind of holding our breath and feeling really anxious about these medications and really about the rise and how quickly they are being prescribed to kids